Search by Drug Name or NDC

    NDC 68382-0544-06 lansoprazole 30 mg/1 Details

    lansoprazole 30 mg/1

    lansoprazole is a ORAL CAPSULE, DELAYED RELEASE PELLETS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 68382-0544
    Product ID 68382-544_b828e447-56b6-4cab-bd49-053bcd4be948
    Associated GPIs 49270040006520
    GCN Sequence Number 030107
    GCN Sequence Number Description lansoprazole CAPSULE DR 30 MG ORAL
    HIC3 D4J
    HIC3 Description PROTON-PUMP INHIBITORS
    GCN 01698
    HICL Sequence Number 008993
    HICL Sequence Number Description LANSOPRAZOLE
    Brand/Generic Generic
    Proprietary Name lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name lansoprazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE PELLETS
    Route ORAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202366
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0544-06 (68382054406)

    NDC Package Code 68382-544-06
    Billing NDC 68382054406
    Package 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68382-544-06)
    Marketing Start Date 2013-08-23
    NDC Exclude Flag N
    Pricing Information N/A